Tenet Healthcare Corporation · Healthcare · Medical Care Facilities
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$239.37
−$0.30 (−0.13%) 4:00 PM ET
After hours$239.39
+$0.02 (+0.01%) 8:19 PM ET
Prev closePrevC$239.67
OpenOpen$239.37
Day highHigh$239.95
Day lowLow$235.56
VolumeVol563,492
Avg volAvgVol1,109,255
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$20.82B
P/E ratio
15.46
FY Revenue
$21.19B
EPS
15.48
Gross Margin
100.00%
Sector
Healthcare
AI report sections
BULLISH
THC
Tenet Healthcare Corporation
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
−48% (Below avg)
Vol/Avg: 0.52×
RSI
73.52(Overbought)
Overbought (>70)
0255075100
MACD momentum
Intraday
+0.12 (Strong)
MACD: 0.20 Signal: 0.08
Short-Term
+2.53 (Strong)
MACD: 10.92 Signal: 8.39
Long-Term
+3.65 (Strong)
MACD: 9.65 Signal: 5.99
Intraday trend score
65.00
LOW55.00HIGH66.00
Latest news
THC•12 articles•Positive: 9Neutral: 3Negative: 0
PositiveBenzinga• Vandana Singh
Tenet Healthcare Quarterly Profit Surges As Hospital, Surgery Demand Grows
Tenet Healthcare reported strong Q4 2025 results with sales of $5.527 billion (up 8.9% YoY) and adjusted EPS of $4.70 (up from $3.44), beating consensus estimates. The company saw growth across both hospital operations and ambulatory segments, driven by higher acuity cases and favorable payer mix. For 2026, Tenet expects revenue guidance of $21.5-$22.3 billion and adjusted EBITDA of $4.485-$4.785 billion, with shares rising 6.73% on the news.
Strong Q2 performance with 3.2% revenue growth, 74% surge in adjusted EPS, expanding margins, robust cash flow, strategic share buybacks, and attractive valuation compared to peers
PositiveThe Motley Fool• Jesterai
Tenet Revenue Tops Estimates in Q2
Tenet Healthcare reported strong Q2 2025 earnings, with adjusted EPS of $4.02, exceeding analyst expectations. The company saw revenue growth in Ambulatory Care and raised its full-year financial guidance, driven by margin improvements and strategic portfolio shifts.
Exceeded earnings expectations, raised full-year guidance, demonstrated revenue growth in Ambulatory Care segment (11.3%), improved margins, increased free cash flow by 23.4%, and strategic portfolio optimization
PositiveBenzinga• Lekha Gupta
Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Several large-cap companies, including Duolingo, CoreWeave, and DexCom, saw significant gains last week due to strong earnings, sales guidance, and analyst upgrades.
Stock escalated after the company reported better-than-expected financial results and raised its FY25 adjusted EPS guidance.
NeutralGlobeNewswire Inc.• The Insight Partners
Plastic Fencing Market to be Driven by Growing Residential and Commercial Construction Activities, Exclusive Research by The Insight Partners
The global plastic fencing market is expected to grow significantly due to rising demand from the residential and commercial construction industries, as well as the increasing adoption of recycled plastics in fencing products.
The article mentions Tenax as one of the major companies operating in the plastic fencing market, but does not provide any specific information about the company's performance or outlook.
PositiveGlobeNewswire Inc.• N/A
Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
Tenax Therapeutics, a Phase 3 pharmaceutical company, announced its participation in the Guggenheim SMID Cap Biotech Conference, where its President and CEO will present in a fireside chat.
TENXTHCTenax Therapeuticspharmaceutical companyGuggenheim SMID Cap Biotech Conference
Sentiment note
The article highlights Tenax Therapeutics' participation in an industry conference, which suggests the company is actively engaged in its business and development efforts.
NeutralBenzinga• Piero Cingari
Trump's Federal Spending Freeze Puts $3 Trillion In Limbo, Threatens Industries Like Clean Energy, Defense, Health Care
The White House has ordered a temporary freeze on all federal grants and loans, putting $3 trillion in funding under scrutiny and threatening industries like clean energy, defense, and healthcare.
The article states that Tenet Healthcare Corp. showed resilience on Tuesday, despite the potential impact of the federal funding freeze on the healthcare industry.
PositiveGlobeNewswire Inc.• Delveinsight
Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight
The article discusses the evolving landscape of rare cardiovascular diseases, including Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy. It highlights the challenges in diagnosis and treatment, as well as the growing market size and pipeline of new therapies for these conditions.
The article mentions Tenax Therapeutics' Imatinib (TNX-201) as a pipeline therapy for Pulmonary Arterial Hypertension, showcasing the company's efforts in addressing this rare disease.
PositiveGlobeNewswire Inc.• Na
Behavioral Rehabilitation Market to Witness 6.9% CAGR by 2031 | SkyQuest Technology
The behavioral rehabilitation market is expected to grow rapidly, driven by increasing mental health awareness and the rising global addiction crisis. The substance abuse disorder segment dominates the market, with a focus on personalized treatments and innovations in telemedicine. North America leads the market due to high awareness of dementia and a strong healthcare system.
The article lists Tenet Healthcare Corporation as a prominent player in the behavioral rehabilitation market, indicating their significant presence and potential to capitalize on the market's expansion.
PositiveBenzinga• Zacks
Ensign Adds 8 Facilities in Kansas & Colorado to Expand Footprint
The Ensign Group has acquired the operations of a nursing facility in Kansas and seven nursing facilities in Colorado, expanding its footprint in these states. The acquisitions are expected to increase the company's revenues and profits.
The article indicates that Tenet Healthcare is a top-ranked stock in the Medical space, with a Zacks Rank #1 (Strong Buy) and strong earnings growth estimates.
NeutralGlobeNewswire Inc.• Researchandmarkets.Com
Europe Pavement Reinforcement Materials (Carbon Fiber, Glass Fiber, Steel Rebar) Industry Analysis Report 2024-2030
The Europe pavement reinforcement materials market is expected to grow at a CAGR of 8.3% from 2024 to 2030, driven by increasing urbanization, smart city initiatives, and the shift towards alternative transportation modes. Key materials include carbon fiber, glass fiber, and steel rebar.
The article mentions TENAX SPA as one of the companies featured, but does not provide any additional information about the company or its performance.
PositiveZacks Investment Research• Zacks.Com
Zacks.com featured highlights Universal Health Services, Tenet Healthcare Corp., Century Communities and Magnite
The article highlights four stocks - Universal Health Services, Tenet Healthcare Corp., Century Communities, and Magnite - that are trading near their 52-week highs and are expected to maintain their momentum and keep scaling new highs.
UHSTENXTHCCCSUniversal Health ServicesTenet Healthcare Corp.Century CommunitiesMagnite
Sentiment note
The article highlights Tenet's revenue growth driven by increasing patient admissions, strategic acquisitions and alliances, divestitures of unprofitable businesses, and strong performance in the Ambulatory Care segment as reasons for the stock's potential to continue climbing.
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal